restless legs
GSK delays US filing of Solzira
November 14, 2008Sales and Marketing GSK, restless legs
GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
